This evidence supports the hypothesis that statins, as well as ezetimibe, possess beneficial pleotropic effects other than LDL lowering, which was not obvious for PCSK9 inhibitors.21, 22, 23 Chronic vascular inflammation plays crucial roles in the pathogenesis of atherosclerosis, which is regarded as a complex pathological process. Here, PCSK9 is linked to atherosclerosis.